119 filings
Page 6 of 6
8-K
urycfczoy cj
5 Aug 15
MacroGenics Provides Update on Corporate Progress and 2014 Financial Results
12:00am
8-K
3swxa
5 Aug 15
Entry into a Material Definitive Agreement
12:00am
8-K
5heoc8k yk
30 Jul 15
MGD011 Advances into Clinical Development
12:00am
8-K
cobbgedehgn
15 Jul 15
MacroGenics Announces Proposed Public Offering of Common Stock
12:00am
8-K
68c41koyerm4f 354o
22 May 15
Submission of Matters to a Vote of Security Holders
12:00am
8-K
46oel9a
6 May 15
Results of Operations and Financial Condition
12:00am
8-K
lfy 8fsyozyaz
3 Mar 15
MacroGenics Provides Update on Corporate Progress and 2014 Financial Results
12:00am
8-K
a2hg9qrcaxmp0s
27 Jan 15
MacroGenics Announces Closing of Collaboration and License Agreement with Janssen to Develop MGD011 for Multiple B-Cell Malignancies
12:00am
8-K
gabbk0
22 Dec 14
MacroGenics Enters Collaboration and License Agreement with Janssen to Develop MGD011 for Multiple B-Cell Malignancies
12:00am
8-K
szik5ooe9z yh
12 Nov 14
MacroGenics Provides Update on Corporate Progress and Third Quarter 2014 Financial Results
12:00am
8-K
iw2au65k fbdmu2p
5 Aug 14
Results of Operations and Financial Condition
12:00am
8-K
tm8n7m8lpkbsb97pp
25 Jul 14
Other Events
12:00am
8-K
ct2qxu4992e1xf0d
11 Jun 14
Submission of Matters to a Vote of Security Holders
12:00am
8-K
g6dd7jsevlzsq9hyz
29 May 14
MacroGenics and Takeda Enter Strategic Alliance to Develop
12:00am
8-K
xdi2o79 k3
6 May 14
Results of Operations and Financial Condition
12:00am
8-K
r927n4lqrqmkzkog73
20 Mar 14
MacroGenics Provides Update on Corporate Progress and 2013 Financial Results
12:00am
8-K
v2rab9 yq
7 Mar 14
Departure of Directors or Certain Officers
12:00am
8-K
0q1jw3r9np 1k7x
12 Nov 13
MacroGenics Provides Corporate Progress Update and Third Quarter 2013 Financial Results
12:00am
8-K
8wmxu4c
18 Oct 13
MacroGenics Announces Closing of Initial Public Offering and Full-Exercise of Over-Allotment Option
12:00am